: Prescription-drug middlemen face mounting pressure from federal government, states

‘Heat wave’ for pharmacy benefit managers as lawmakers, regulators scrutinize impact on drug prices 

Previous post Top Ten: How the FDIC has set a ‘baseline’ for troubled commercial real estate
Next post Economic Report: Consumer sentiment falls to three-month low on recession worries